The anti-mitotic drug griseofulvin induces apoptosis of human germ cell tumor cells through a connexin 43-dependent molecular mechanism.

Griseofulvin, a widely used antifungal antimitotic drug has been proposed as an anti-tumoral treatment by way of in vitro experiments. Recently, in vivo demonstration of griseofulvin efficacy against multiple myeloma in mice argues for its potential as therapeutics for cancer. Nevertheless, the molecular mechanisms by which griseofulvin disrupts cancerous cell progression are far from being understood. In the present study, we found that griseofulvin inhibits human germ cell tumor cell growth through activation of mitochondrial caspase pathway (caspase 9 and 3) leading to the activation of apoptosis rather than an alteration of cell proliferation. Strikingly, we demonstrated that griseofulvin triggered the expression level of connexin 43 (mRNA and protein), a well described tumor-suppressor gene, known to participate in apoptosis regulation. Consistently, together with microtubule instability, a mechanism classically associated with cell death in response to griseofulvin, we observed a disruption of connexin 43/tubulin association concomitant of an enhanced translocation of connexin 43, or an immunoreactive fragment of the protein, from the cytoplasm to the nucleus. Finally, by using siRNA approaches we demonstrated the requirement of connexin 43 in the apoptotic induction of griseofulvin on our tumor cell model. Altogether, these results described a new molecular mechanism connexin 43-dependent targeted by griseofulvin leading to apoptosis of human germ cell tumor cells.

Connexins as precocious markers and molecular targets for chemical and pharmacological agents in carcinogenesis.

Gap junctions, intercellular channels structured by the connexin protein family, have been implicated in the control of cell homeostasis, proliferation, differentiation and death. A loss of the gap junction intercellular communication and/or connexin dysfunction are typical features of cancer per se and have been associated with the effect of many carcinogens. Indeed, many early human neoplasia of various organs and human tumor cell lines exhibit deficient connexin-mediated communication expression mainly related, in a large number of observations, with an aberrant cytoplasmic localization of this membranous protein. Restoration of normal phenotype in transformed cells by restoration of exogenous connexin gave rise to the concept that connexins may act as tumor suppressors. However, the mechanisms by which connexins mediate such a tumor suppressor effect are multiple. They may result from: formation of functional channels; hemichannels or are directly associated with connexin expression. In addition, the literature shows that they may be dependent upon the cell type and the connexin type. In the present review, we analyze all these aspects of connexin/gap junction involvement in the carcinogenesis process, in human cancers and discuss the possibility of using connexins as potential anti-oncogenic targets for cancer chemoprevention and/or chemotherapy.

Ultrastructural localization and distribution of Nardilysin in mammalian male germ cells.

BACKGROUND: NRD convertase, also termed Nardilysin, is a Zn(++) metalloendopeptidase that specifically cleaves the N-terminus of arginine and lysine residues into dibasic moieties. Although this enzyme was found located within the testis, its function in male reproduction is largely unknown. In addition, the precise distribution of this enzyme within germ cells remains to be determined. METHODS: To answer these questions, we developed an immuno-gold electron microscopy analysis to detect Nardilysin at ultrastructural level in mice. In addition, we performed a quantitative analysis of these gold particles to statistically estimate the distribution of Nardilysin in the different subcellular compartments of differentiating late spermatids/spermatozoa. RESULTS: Expression of Nardilysin in wild-type mice was restricted to germ cells and markedly increased during the last steps of spermiogenesis. In elongated spermatids, we found the enzyme mainly localized in the cytoplasm, more precisely associated with two microtubular structures, the manchette and the axoneme. No labelling was detected over the membranous organelles of the spermatids. To test whether this localization is dependent of the functional microtubules organization of the flagella, we analysed the localization into a specific mouse mutant ebo/ebo (ébouriffé) known to be sterile due to an impairment of the final organization of the flagellum. In the ebo/ebo, the enzyme was still localized over the microtubules of the axoneme and over the isolated cytoplasmic microtubules doublets. Quantification of gold particles in wild-type and mutant flagella revealed the specific association of the enzyme within the microtubular area of the axoneme. CONCLUSIONS: The strong and specific accumulation of Nardilysin in the manchette and axoneme suggests that the enzyme probably contributes either to the establishment of these specific microtubular structures and/or to their functional properties.

OBJECTIFS: La NRD convertase aussi appelée Nardilysine, une Zn++ metalloendopeptidase qui clive spécifiquement dans la région N terminale des résidus arginine et lysine des sites dibasiques, est impliquée dans la transformation/maturation des proprotéines. Le but de cette étude est de localiser cette enzyme durant la spermiogénèse afin de comprendre son rôle au cours de la maturation des spermatides. MÉTHODES: La Nardilysine est révélée par immunohistochimie au niveau ultrastructural chez des souris contrôles fertiles et chez un mutant stérile (ébouriffé : ebo/ebo). Des analyses quantitatives sont effectuées par comptage des grains d'or colloïdal qui permettent de détecter la localisation spécifique de l'enzyme au cours de la croissance des spermatides dans des régions particulières. RÉSULTATS: L'expression de la Nardilysine chez les souris sauvages et stériles ebo/ebo est limitée aux cellules germinales avec une augmentation significative dans les étapes ultimes de la spermiogénèse. L'enzyme est fortement exprimée dans le cytoplasme des spermatides allongées et dans les structures microtubulaires, la manchette et le flagelle. Aucun marquage n'est observé au niveau des organites cellulaires des spermatides. Chez le mutant ebo/ebo, dont le flagelle est anormal, l'enzyme est toujours présente sur les doublets de microtubules du flagelle. La quantification des particules d'or chez la souris sauvage et chez le mutant révèle une association spécifique de l'enzyme avec les microtubules du flagelle. CONCLUSIONS: L'accumulation spécifique de la Nardilysine au niveau de la manchette et du flagelle suggère que cette enzyme pourrait contribuer à l'établissement de ces structures microtubulaires particulières et/ou à leurs propriétés fonctionnelles.

Expression in transgenic mice of the large T antigen of polyomavirus induces Sertoli cell tumours and allows the establishment of differentiated cell lines.

The large T antigen of polyomavirus (PyLT) efficiently immortalizes rodent fibroblasts, but, unlike SV40 T antigen, it is not sufficient to achieve complete oncogenic transformation. We analysed a series of transgenic mouse families that express the PyLT protein under control of the viral enhancer-promoter region. In all of them, the transgene was expressed in the seminiferous epithelium of the testis (Sertoli and germ cells), with no pathological consequences during most of the animals' lives. However, every old male developed large bilateral tumours of the testes, generated by the proliferation of Sertoli cell derivatives. Cell lines could be readily established both from the tumours and from the still apparently normal testis before the onset of tumoral growth. They retained in vitro morphological and ultrastructural features characteristic of Sertoli cells. But, in addition to this major Sertoli component, the maintenance of a cellular contingent of germinal origin was suggested by the expression of genes that are normally transcribed during the premeiotic and early meiotic stages of spermatogenesis (LDH-X, Hox1.4 and c-kit). The two cell types remained tightly associated, even at late passages in culture, and could not be separated by conventional cloning procedures. This association in culture of the two cell types whose interaction is critical for spermatogenesis may provide a useful tool for its molecular analysis.

Estrogen-induced growth inhibition of human seminoma cells expressing estrogen receptor beta and aromatase.

It is now well established that estrogens participate in the control of normal spermatogenesis and endogenous or environmental estrogens are involved in pathological germ cell proliferation including testicular germ cell tumors. Studying a human testicular seminoma cell line, JKT-1, we show here that 17beta-estradiol (10(-12) to 10(-6) M) induced in vitro a significant dose-dependent decrease of cell growth. This antiproliferative effect was maximum after 4 days of exposure at a physiologically intratesticular concentration of 10(-9) M, close to the K(d) of ER, and reversed by ICI 182780, an ER antagonist, suggesting an ER-mediated pathway. By RT-PCR and Western blot we were able to confirm that JKT-1, like tumoral seminoma cells and normal human testicular basal germ cells, expresses estrogen receptor beta (ERbeta), including ERbeta1 and ERbeta2, a dominant negative variant, but not ERalpha. Using immunofluorescence and confocal microscopy, ERbeta was observed as perinuclear intracytoplasmic spots in JKT-1 and tumoral seminoma cells without significant translocation of ERbeta into the nucleus, under 17beta-estradiol exposure. Double staining observed by confocal microscopy revealed that ERbeta colocalized in JKT-1 cells with cytochrome C, a mitochondrial marker. We report for the first time the expression of a functional aromatase complex in seminoma cells as assessed by RT-PCR, Western blot and enzymatic assay. Seminoma cells are able to respond to estrogens through a possible autocrine or paracrine loop. These preliminary results support estrogen-dependency of human testicular seminoma, the most frequent tumor of young men, and suggest potential pharmacological use. Whether this estrogen control, however, involves an ERbeta-mediated stimulation of cell apoptosis and/or an ERbeta-mediated inhibition of cell proliferation, remains to be further determined.

Developmental changes in arginine vasopressin receptors and testosterone stimulation in Leydig cells.

The steroidogenic response of purified Leydig cells from mice at various ages (from 10-95 days old) was investigated after exposure of cells to arginine vasopressin (AVP) or oxytocin (OT). A 24-h pretreatment by the neurohypophysial hormones significantly increased the acute (3-h) testosterone production by 1.3- to 3-fold at all ages studied, with the exception of pubertal Leydig cells which responded with a 5- to 7-fold increment of testosterone production (P less than 0.05). The higher responsiveness of pubertal Leydig cells to AVP does not result from an increased sensitivity, since the half-maximal effective doses (ED50) of AVP needed to stimulate testosterone production were quite similar and were in nanomolar range for both pubertal and adult Leydig cells. In addition, the ED50 for OT was 10 times higher than that for AVP. Cycloheximide totally abolished the AVP stimulation, suggesting that the AVP effect is dependent upon new protein synthesis. No modification of hCG-stimulated testosterone production occurred after a 24-h pretreatment of Leydig cells by AVP or OT for all ages studied. A 72-h AVP pretreatment resulted in a marked decrease (50-60%) in acute hCG-stimulated testosterone production in both pubertal and adult Leydig cells. Binding studies of [3H]AVP to purified Leydig cells from prepubertal, pubertal, and adult mice showed the presence of a single set of high affinity V1 sites. The Kd values, in the nanomolar ranges, remained unchanged regardless of age. Maximal capacities were of the same order in the prepubertal and adult Leydig cells (9,460 vs. 10,314 sites/cell), while a 50% decrease (P less than 0.01) in the number of AVP receptors occurred in pubertal Leydig cells (5,048 sites/cell). These data indicate developmental changes in the steroidogenic responsiveness of Leydig cells to neurohypophysial hormones and suggest that AVP receptors might be under a regulatory mechanism(s) during puberty. They provide additional evidence for participation of neurohypophysial hormones in autocrine/paracrine regulation of testicular steroidogenesis.

Disappearance of beta-adrenergic response of human myometrial adenylate cyclase at the end of pregnancy.

The density of beta-adrenergic receptors in both the outer and inner layers of the human myometrium decreases during the last weeks of pregnancy. Although in preterm myometrium (32-35 weeks of pregnancy) beta-adrenergic receptors are positively coupled to adenylate cyclase, we found that isoproterenol, epinephrine, and norepinephrine did not stimulate the enzyme in the inner or outer myometrial layer at term (39-40 weeks of pregnancy). At this stage, the addition of 10(-4) mol/L guanyl-5'-imidodiphosphate increased (from 10(-8) to 10(-4) mol/L) basal adenylate cyclase activity in a dose-dependent manner, indicating that the catalytic component of the enzyme remains linked to the stimulatory guanyl nucleotide binding protein (Gs). Compared to the preterm response, at term the myometrial adenylate cyclase response to 10(-4) mol/L guanyl-5'-imidodiphosphate was decreased, which may reflect a decrease in the amount of functional Gs. Altogether these changes are consistent with reduced Gs coupling to the catalytic component. However, the similarity of the responses of preterm and term myometrium to forskolin excluded the possibility of an alteration of the catalytic component of adenylate cyclase during the last weeks of pregnancy. The fact that a stimulatory effect of isoproterenol on adenylate cyclase was found after islet-activating protein pretreatment indicates that human term myometrium contains a functional inhibitory guanyl nucleotide binding protein which is involved in the modulation of the beta-adrenergic adenylate cyclase response. Our data suggest that modifications in the coupling mechanisms between receptors and the catalytic component are implicated in the loss of beta-adrenergic adenylate cyclase stimulation in the myometrium at the end of pregnancy.

AVP receptors of mouse Leydig cells are regulated by LH and E2 and influenced by experimental cryptorchidism.

Exposure of pubertal mouse Leydig cells for 24 h to increasing concentrations (1-100 ng/ml) of LH elicited a dose-dependent decrease in AVP receptor content. Maximal reduction (50%) was obtained at a dose of 10 ng/ml LH. A similar treatment applied to adult Leydig cells did not influence AVP receptor density. Treatment of adult Leydig cells for 24 h by E2 (5-500 ng/ml) resulted in a dose-dependent increase in AVP receptor content. About 50% increase was achieved with 500 ng/ml E2. AVP receptor content in pubertal Leydig cells was not modified irrespective of the concentration of E2 tested. These changes in AVP receptor number were well correlated with the response of Leydig cells to AVP (10(-6) M) in terms of testosterone production. 2 weeks bilateral cryptorchidism resulted in reduction of testicular weight, circulating testosterone levels associated with a marked rise in Leydig cell AVP receptor density with no change of affinity. Testosterone production by Leydig cells from cryptorchid testes in response to AVP (10(-6) M) or hCG (100 ng/ml) stimulation was reduced compared to that of control Leydig cells. This study provides new arguments supporting the concept that AVP could be involved in local regulation of testicular steroidogenesis.

A proposed role for ZO-1 in targeting connexin 43 gap junctions to the endocytic pathway.

Gap junctions are intercellular channels organized in plaque that directly link adjacent cells. Connexins (Cx), the constitutive proteins of gap junctions are associated with several partner proteins (cytoskeletal, anchoring) which could participate in plaque formation and degradation. Coimmunoprecipitation and indirect immunofluorescence analyses showed that ZO-1, a tight junction-associated protein, was linked to Cx43 in the testis. By using gamma-hexachlorocyclohexane (HCH), known to induce gap junction endocytosis, we demonstrated that endocytosis increased Cx43/ZO-1 association within the cytoplasm of treated Sertoli cells. In control cells, the two proteins were present, as expected, at the plasma membrane level, but poorly colocalized. The increased intracytoplasmic Cx43/ZO-1 complex was associated with a shift towards increased levels of Cx43 P1 and P2 isoforms. The HCH induced Cx43 hyperphosphorylation was abolished by the ERK inhibitor PD98059 suggesting that this effect could be mediated through activation of the ERK pathway. These data strongly support a novel role for ZO-1 in the turnover of Cx43 during gap junction plaque endocytosis.

Connexin43 gene expression and regulation in the rodent seminiferous epithelium.

Connexin43 (Cx43) is one of the most predominant gap junction proteins found in the testis. We used in situ hybridization and indirect immunofluorescence to study the distribution of Cx43 mRNA and protein in the rodent seminiferous epithelium. During mouse testis maturation, Cx43 mRNA and its corresponding protein were first detected in the adluminal compartment of the growing seminiferous tubules (early postnatal age: Day 12) to become progressively located in the basal compartment at later ages (Days 16, 19, 27). In seminiferous tubules of sexually mature animals, the intensity of the hybridization signal was stage-dependent, with a maximum at Stage VII compared with Stages V and IX of the spermatogenic cycle (p<0.05). The highest expression of Cx43 mRNA was observed in the supporting Sertoli cells and, to a lesser extent, in the most basally located and less mature germ cells (spermatogonia and spermatocytes). Consistent with these observations, in situ dye coupling was observed between Sertoli cells and basal germ cells. In a mutant mouse deficient for the retinoid X receptor beta, which exhibited abnormal spermatogenesis due to altered Sertoli cell function, Cx43 transcripts were markedly decreased in the seminiferous epithelium (p<0.01). The immunoreactive signal for Cx43 was significantly reduced in seminiferous tubules of the 3-month-old mutant mice (p<0.05) and undetectable in older animals. These data provide new information about the precise localization of Cx43 mRNA and protein in seminiferous tubules of immature and mature rodent testes. Moreover, they suggest that retinoids, through the RXRbeta receptors, could be involved in the control of Cx43 gene expression in Sertoli cells.

Regulation of testosterone production in Leydig cells from fetal mice under dynamic conditions: effect of human chorionic gonadotrophin and 8-bromo-cyclic AMP.

The temporal release of testosterone by Leydig cells from 18-day-old mouse fetuses in response to human chorionic gonadotrophin (hCG) and to 8-bromocyclic AMP (8-bromo-cAMP) was investigated under short-term incubation (180 min) conditions. A rapid and large increase in testosterone release was induced by a 5-min exposure to hCG (20 i.u./l) or 8-bromo-cAMP (10 mmol/l). The testosterone response of fetal Leydig cells to the two gonadotrophic stimuli was Gaussian in distribution with a peak value of testosterone by 15-20 min. Repeated exposure to hCG resulted in a reduced testosterone response but an increased accumulation of cAMP. The apparent resistance of fetal Leydig cells to hCG could not be overcome either by increasing the hCG concentration (to 2000 i.u./l) or by exposing the cells to 8-bromo-cAMP (10 mmol/l). Continuous exposure to hCG (200 i.u./l) divided into multiple small doses (each 8 i.u./l) induced testosterone secretion with different kinetic characteristics: a three-fold longer time-lag between hormone exposure and the peak value; a twofold greater testosterone response (P less than 0.001) and a gradual decrease of testosterone secretion. Oestradiol significantly reduced basal and hCG-stimulated testosterone production only at a high concentration (10 mumol/l). These results indicate that continuous or pulsatile exposure to hCG can induce refractoriness of fetal Leydig cells. The similarity between the actions of hCG and 8-bromo-cAMP on fetal steroidogenesis suggests that this rapid defect is not primarily due to a depletion of gonadotrophin receptors but results from disruption of regulatory mechanisms at the post-receptor level.

Gonado-pituitary relationships in the fetal mouse at various times during sexual differentiation.

Levels of testosterone in plasma and concentrations of LH in both plasma and pituitary glands of fetal mice aged 14, 16 and 18 days were measured by radioimmunoassays in a representative number of fetuses. During this period levels of testosterone in the plasma of male mice were significantly higher than those in the females. Levels of testosterone in plasma of male mice increased from day 14 to day 16 of gestation and decreased on day 1 before parturition. Plasma concentrations of LH remained undetectable in male and female fetuses until day 16 of gestation. levels of LH rose slightly in both sexes in later gestation, but still remained significantly lower in the plasma of male fetuses on days 17-18. In contrast, higher but not significantly different concentrations of LH were observed in pituitary glands from days 14 to 18 in male compared with female mice. These observations suggest that the high levels of testosterone in the plasma of male fetal mice might be responsible for feedback inhibition of LH secretion during the last days of gestation.

Presence in mouse Sertoli cell-conditioned medium of a factor that expresses AVP-like inhibition of steroidogenesis by mouse Leydig cells in long-term culture.

The influence of spent medium from immature mouse Sertoli cells (SCM) on testosterone production by purified Leydig cells was investigated and compared to that of AVP, a potent local modulator of Leydig cell steroidogenesis. SCM inhibited in a dose-dependent manner the hCG-stimulated testosterone production, but was ineffective in basal conditions. As is known for AVP, (i) a lag period of 72 h was prerequisite for SCM to inhibit Leydig cell function; (ii) the main effect of SCM was located at a step beyond the receptor-adenylate cyclase system, since the hCG- and 8-bromo-cAMP-stimulated testosterone productions were similarly affected. The possibility that the effect of SCM may be related to AVP-like molecule(s) is also supported by the observations that at maximal concentrations the inhibitory effects of AVP and SCM were not additive and that the inhibition of testosterone production was largely (65%) reversed by the presence of [(beta-mercapto-beta, beta-cyclopentamethylenepropionyl, O-Me-Tyr2,Arg8)-vasopressin], a selective vasopressor antagonist. These data indicate that Sertoli cells produce in vitro potent inhibitory factors of Leydig cell steroidogenesis. They provide additional evidence that one of these bioactive factors has an effect on Leydig cell function similar to that of AVP.

Local control of Leydig cell arginine vasopressin receptor by naloxone.

Arginine vasopressin (AVP) and beta-endorphin are present within the testis where they could act as paracrine effectors of steroidogenesis. In this study we investigated the effect of naloxone, an opioid receptor antagonist on Leydig cell AVP receptor. Intratesticular injection of increasing doses of naloxone (0.1-100 micrograms) resulted 24 h later in a dose-dependent increase in Leydig cell AVP binding capacity. This effect occurred locally since s.c. injection of similar doses of naloxone did not alter the testicular AVP receptor content and intratesticular injection enhanced AVP receptor density only in the naloxone-treated testis but not in the contralateral vehicle-treated testis. Scatchard plot analysis of the data revealed that naloxone locally injected altered AVP binding capacity without change in affinity. These results suggest that in addition to their known paracrine effects in the testis, endogenous opioid peptides may locally control the testicular AVP system by modulating AVP receptor capacity.

Involvement of gap junctional communication and connexin expression in trophoblast differentiation of the human placenta.

Gap junctional intercellular communication (GJIC) permits coordinated cellular activities during development and differentiation processes, and its dysfunction or mutation of connexin genes have been implicated in pathologies. In the human placenta, two distinct differentiation pathways of cytotrophoblastic cell coexist leading to a double model: fusion phenotype (villous trophoblast) and proliferative/invasive phenotype (extravillous trophoblast). This review focuses on current knowledge on the connexin expression and the implication of GJIC in trophoblastic differentiation. Experimental evidence obtained in human placenta demonstrates the involvement of connexin 43-gap junctions in the trophoblastic fusion process and of a connexin switch during the spatially and temporally controlled proliferation/invasion process.

Modulation of mouse Leydig cell steroidogenesis through a specific arginine-vasopressin receptor.

Characterization of specific vasopressin binding sites was investigated in purified mouse Leydig cells using tritiated arginine-vasopressin. Binding of radioligand was saturable, time- and temperature-dependent and reversible. (3H)-AVP was found to bind to a single class of sites with high affinity (Kd = 2.20 +/- 0.18 nM) and low capacity (Bmax = 17.4 +/- 1.8 fmol/10(6) Leydig cells). Binding displacements with specific selective analogs of AVP indicated the presence of V1 subtype receptors on Leydig cells. The ability of AVP to displace (3H)-AVP binding was greater than LVP and oxytocin. The unrelated peptides, somatostatin and substance P, were less potent, while neurotensin and LHRH did not displace (3H)-AVP binding. The time-course effects of AVP-pretreatment on basal and hCG-stimulated testosterone and cAMP accumulations were studied in primary culture of Leydig cells. Basal testosterone accumulation was significantly increased by a 24 h AVP-pretreatment of Leydig cells (P less than 0.001). This effect was potentiated by the phosphodiesterase inhibitor (MIX) and was concomitantly accompanied by a slight but significant increase in cAMP accumulation (P less than 0.01). AVP-pretreatment of the cells for 72 h had no effect on basal testosterone accumulation, but exerted a marked inhibitory effect on the hCG-stimulated testosterone accumulation (P less than 0.001). This reduction of testosterone accumulation occurred even in the presence of MIX and was not accompanied by any significant change of cAMP levels. We conclude from these data that AVP is capable of modulating steroidogenesis in Leydig cells through specific and functionally V1 receptor subtype and postulate that this effect may be part of an intratesticular paracrine/autocrine control mechanism.

[Steroid sulfatase and placental deficiency. Current data as instigators of new research]. / Stéroïde sulfatase et déficit placentaire. Données récentes instigatrices de nouvelles investigations.

Arylsulfate sulfohydrolases, ubiquitously distributed, mediate the hydrolysis of sulfoconjugated steroids found in large amounts in a variety of human tissues and fluids. The sterol sulfate sulfohydrolase (steroid sulfatase), bound to the microsomal fraction, is capable of hydrolyzing natural substrates such as cholesterol and dehydroepiandrosterone sulfates. The placenta is the richest source of the enzyme. The physiological interest of this enzymatic activity became apparent when placental steroid sulfatase deficiency was described in pregnancies with strikingly low oestrogen levels in the maternal plasma and urine. This enzymopathy appears to have only a moderate pejorative incidence on the mode of delivery, thus intervention is unnecessary unless dictated by fetal and/or maternal associated pathology. The disorder is transmitted on the X-linked recessive mode of inheritance and affected individuals, all males, present with ichthyoses of the sex-linked type. The gene coding for the steroid sulfatase enzyme has been assigned to the distal part of the X-chromosome in the Xp22.3-Xpter region which is known to escape the inactivation process. The lack of enzymatic activity in the somatic tissues of the patients is followed by an increase of the circulating sulfated steroid levels and by an accumulation of cholesterol sulfate in blood and skin. The modified electrophoretic mobility of the low-density lipoproteins, which might result from the excess of cholesterol sulfate bound to these lipoproteins, is a new diagnostic clue for the enzymopathy. Apart from the modification recognized to be systematically associated to the steroid sulfatase deficiency, numerous cases of hypogonadism and cryptorchidism have been recently described and may be considered as new clinical manifestations of this genetic disorder. Recent cloning of the gene coding for the steroid sulfatase should allow the molecular study of the etiology of this inborn error of metabolism.

[Study of Leydig cells and gonadotropin activity in 14-18 days old fetal mouse (author's transl)]. / Etude de l'activité leydigienne et gonadotrope chez l'embryon de souris mâle en fin de gestation.

An organ culture system has been developed for mouse embryo testes and pituitaries at 14-18 days of gestation. The testosterone (T) production by fetal testes has been measured by RIA in the culture medium: it increases from day 14 to day 18 and may be specifically stimulated by ovine LH and hCG. Fetal pituitaries in culture release a gonadotropin activity at 16 and 18 days (not found at 14 days), which is detectable by an heterologous RIA of LH and by a significant increase in T production from age-matched testes in co-culture. The 18-days old pituitaries respond to synthetic LH-RH by an enhanced production of immunologically and biologically active LH.

[Intragonadal control of testicular function by neurohypophyseal-like peptides]. / Contrôle intragonadique de la fonction testiculaire par les peptides de type neurohyphysaire.

Immunochemical studies associated with physicochemical procedures led to demonstrate the presence of neurohypophysial-like peptides in the testis of numerous species including human. Characterization of arginine-vasopressin-neurophysin II mRNA and oxytocin-neurophysin I mRNA in rat testicular extracts is in favour of a local production for these peptides. The in vitro and in vivo evidences of a direct regulation of testicular steroidogenesis bg AVP and related peptides--the identification of specific AVP receptors on purified Leydig cells and their alteration in some physiological or pathological situations argue for a paracrine/autocrine role of these neurohypophysial-like-peptides in modulating Leydig cell androgen biosynthesis.

The emerging role of connexin 43 in testis pathogenesis.

Direct intercellular communication is mediated by gap junctions and their constitutive proteins, the connexins, which are organized in a hexameric arrangement forming a channel between adjacent cells. Connexins are essential for cell homeostasis and are also involved in many physiological processes such as cell growth, differentiation and death. Spermatogenesis is a sophisticated model of germ cell proliferation, differentiation, survival and apoptosis, in which one connexin isoform, connexin 43, plays an essential role as evidenced by the targeted genetic deletion of Cx43 gene. A controlled balance of germ cell growth is a prerequisite to maintain either normal level of spermatozoa necessary for fertility and/or to limit an uncontrolled and anarchic germ cell proliferation, a major risk for germ cell tumor cell development. In the present review, we highlight the emerging role of connexins in testis pathogenesis, specifically in two intimately interconnected human testicular diseases: azoospermia with impaired spermatogenesis and testicular germ cell tumors, whose incidence increased during the last decades. This review proposes the gap junction protein connexin 43 as a new potential cancer diagnostic and prognostic marker, as well as a promising therapeutic target for testicular diseases.